Regeneron Pharmaceuticals Inc (REGN) — Cash Flow Reinvestment Rate
Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Reinvestment Rate of 0.35x as of March 2026, reinvesting $380.00 Million (capex $230.60 Million plus investments $-149.40 Million) from operating cash flow of $1.08 Billion. Check Regeneron Pharmaceuticals Inc (REGN) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Regeneron Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Regeneron Pharmaceuticals Inc across 16 annual periods. Explore REGN long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Regeneron Pharmaceuticals Inc (2006–2025)
Year-by-year capital reinvestment analysis for Regeneron Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of Regeneron Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | $1.49 Billion | $4.98 Billion | $898.40 Million | ▼ -59.1% |
| 2024 | 0.73x | $3.22 Billion | $4.42 Billion | $755.90 Million | ▼ -43.2% |
| 2023 | 1.28x | $5.90 Billion | $4.59 Billion | $926.40 Million | ▲ +154.9% |
| 2022 | 0.50x | $2.53 Billion | $5.01 Billion | $590.10 Million | ▼ -33.7% |
| 2021 | 0.76x | $5.38 Billion | $7.08 Billion | $551.90 Million | ▲ +71.8% |
| 2020 | 0.44x | $1.16 Billion | $2.62 Billion | $614.60 Million | ▼ -47.0% |
| 2019 | 0.83x | $2.03 Billion | $2.43 Billion | $429.60 Million | ▲ +26.1% |
| 2018 | 0.66x | $1.45 Billion | $2.20 Billion | $383.10 Million | ▼ -13.9% |
| 2017 | 0.77x | $1.01 Billion | $1.31 Billion | $272.60 Million | ▲ +9.2% |
| 2016 | 0.70x | $1.05 Billion | $1.49 Billion | $511.90 Million | ▲ +3.3% |
| 2015 | 0.68x | $907.60 Million | $1.33 Billion | $677.93 Million | ▲ +22.0% |
| 2014 | 0.56x | $420.78 Million | $752.43 Million | $333.01 Million | ▼ -7.4% |
| 2013 | 0.60x | $355.45 Million | $588.60 Million | $156.32 Million | ▼ -86.4% |
| 2010 | 4.44x | $428.21 Million | $96.34 Million | $99.69 Million | ▲ +559.5% |
| 2007 | 0.67x | $18.45 Million | $27.37 Million | $18.45 Million | ▲ +453.2% |
| 2006 | 0.12x | $2.81 Million | $23.07 Million | $2.81 Million | — |